Some of the most prominent names in biotechnology plunged on Thursday as the Nasdaq headed for its worst day in nearly two years.
Read MoreThe latest on the markets
Jim Cramer goes off the charts to look at the volatility index and sees a bumpy ride ahead for March.
Jim Cramer is scared of the issues coming out of China. He steers clear.
David Rubenstein also says the pre-IPO investment market has changed considerably from the period before the tech bubble burst.
Check out which companies are making headlines after the bell Tuesday: Smith & Wesson, TiVo, Bob Evans & more.
Get the best of CNBC in your inbox